Filing metadata

Accession number
0001415889-25-008790
Form type
Form 4
Filer
Enliven Therapeutics, Inc.
CIK
CIK 1672619
Filed
Mar 21, 2025
Reporting period
Mar 19, 2025
Description
Insider transaction

Explore SEC Filings Hub